The CSIC has developed an eco-friendly adhesive with properties and characteristics unique in the industry. In addition to high mechanical and chemical resistance, its ease of application and low production cost make this an ideal adhesive for a wide range of surfaces. We are seeking companies interested in acquiring the patent licence, to undertake the development of new adhesive products.

The CSIC has developed an immunotherapy approach based on a bifunctional compound for the treatment and prevention of prostate cancer, the second most common cancer worldwide for men and fifth most common cancer overall. Industrial partners from the pharmaceutical industry are being sought, for collaboration through a patent licence agreement.